12.51
0.45 (3.73%)
0.45 (3.73%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,182,460 |
|
|||||
| News | - | ||||||
| Day High | 12.60 | Low High |
|||||
| Day Low | 11.91 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.45 | 3.73% | 12.51 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.47 | 11.91 | 12.60 | 12.11 | 12.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,148 | 1,182,460 | $ 12.33 | $ 14,579,248 | - | 8.795 - 36.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:30:51 | formt | 100 | $ 12.51 | USD |
Period:
Draw Mode:
BioXcel Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 350.09M | 27.99M | 14.78M | $ - | $ - | -4.07 | -2.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 418.15k | 0.70% |
BioXcel Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.17 | 12.60 | 9.17 | 10.67 | 918,558 | 3.34 | 36.42% |
| 1 Month | 11.62 | 12.75 | 8.795 | 10.55 | 676,422 | 0.89 | 7.66% |
| 3 Months | 21.04 | 25.50 | 8.795 | 15.09 | 959,437 | -8.53 | -40.54% |
| 6 Months | 22.72 | 25.50 | 8.795 | 16.00 | 615,223 | -10.21 | -44.94% |
| 1 Year | 32.10 | 36.49 | 8.795 | 19.97 | 467,798 | -19.59 | -61.03% |
| 3 Years | 10.95 | 74.89 | 3.76 | 32.38 | 435,671 | 1.56 | 14.25% |
| 5 Years | 11.02 | 74.89 | 2.41 | 30.86 | 325,876 | 1.49 | 13.52% |
BioXcel Therapeutics Description
| BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |